Vogt Frederick G: insider trades.
Vogt Frederick G reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Vogt Frederick G
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Iovance Biotherapeutics, Inc. (IOVA) | Director, Officer · Interim CEO & General Counsel | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Iovance Biotherapeutics, Inc. | M | 15,626 | $0 | 602,085 | Form 4 |
| 2026-09-08 | Iovance Biotherapeutics, Inc. | F | 6,638 | $8.7 | 595,447 | Form 4 |
| 2026-09-01 | Iovance Biotherapeutics, Inc. | M | 41,669 | $0 | 604,161 | Form 4 |
| 2026-09-01 | Iovance Biotherapeutics, Inc. | F | 17,702 | $8.28 | 586,459 | Form 4 |
Questions
What stock did Vogt Frederick G buy or sell?
Vogt Frederick G reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Vogt Frederick G the same person as other filers with this name?
This page covers SEC CIK 1719678 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/vogt-frederick-g-1719678.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.